BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8426198)

  • 21. Salvage therapy of progressive and recurrent Hodgkin's disease: results from a multicenter study of the pediatric DAL/GPOH-HD study group.
    Schellong G; Dörffel W; Claviez A; Körholz D; Mann G; Scheel-Walter HG; Bökkerink JP; Riepenhausen M; Lüders H; Pötter R; Rühl U;
    J Clin Oncol; 2005 Sep; 23(25):6181-9. PubMed ID: 16135485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of risk factors in patients treated for first relapse of Hodgkin's disease.
    Lohri A; Connors JM
    Leuk Lymphoma; 1994 Oct; 15(3-4):189-200. PubMed ID: 7866268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR).
    Lazarus HM; Loberiza FR; Zhang MJ; Armitage JO; Ballen KK; Bashey A; Bolwell BJ; Burns LJ; Freytes CO; Gale RP; Gibson J; Herzig RH; LeMaistre CF; Marks D; Mason J; Miller AM; Milone GA; Pavlovsky S; Reece DE; Rizzo JD; van Besien K; Vose JM; Horowitz MM
    Bone Marrow Transplant; 2001 Feb; 27(4):387-96. PubMed ID: 11313668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extended-field radiotherapy is superior to MOPP chemotherapy for the treatment of pathologic stage I-IIA Hodgkin's disease: eight-year update of an Italian prospective randomized study.
    Biti GP; Cimino G; Cartoni C; Magrini SM; Anselmo AP; Enrici RM; Bellesi GP; Bosi A; Papa G; Giannarelli D
    J Clin Oncol; 1992 Mar; 10(3):378-82. PubMed ID: 1740677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changing patterns of relapse in Hodgkin's disease.
    Duchesne G; Crow J; Ashley S; Brada M; Horwich A
    Br J Cancer; 1989 Aug; 60(2):227-30. PubMed ID: 2765370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy.
    Proctor SJ; Taylor PR; Angus B; Wood K; Lennard AL; Lucraft H; Carey PJ; Stark A; Iqbal A; Haynes A; Russel N; Leonard RC; Culligan D; Conn J; Jackson GH
    Eur J Haematol Suppl; 2001 Jul; 64():28-32. PubMed ID: 11486397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. "Very late" relapses in Hodgkin's disease patients: a rare but real phenomenon.
    Zinzani PL; Mazza P; Gherlinzoni F; Bocchia M; Bendandi M; Fiacchini M; Tura S
    Haematologica; 1992; 77(5):435-7. PubMed ID: 1483597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Results of radiotherapy and combined modality treatment in early stage high grade non-Hodgkin's lymphoma.
    Frank C; Flentje M; Goldschmidt H; Hunstein W; Wannenmacher M
    Strahlenther Onkol; 1994 Jul; 170(7):383-90. PubMed ID: 8052937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic factors for patients relapsing after radiotherapy for early-stage Hodgkin's disease.
    Roach M; Brophy N; Cox R; Varghese A; Hoppe RT
    J Clin Oncol; 1990 Apr; 8(4):623-9. PubMed ID: 2313331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical stages I and II Hodgkin's disease: a specifically tailored therapy according to prognostic factors.
    Carde P; Burgers JM; Henry-Amar M; Hayat M; Sizoo W; Van der Schueren E; Monconduit M; Noordijk EM; Lustman-Marechal J; Tanguy A
    J Clin Oncol; 1988 Feb; 6(2):239-52. PubMed ID: 2578012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Salvage chemotherapy with mini-BEAM for relapsed or refractory Hodgkin's disease prior to autologous peripheral blood stem cell transplantation.
    Fernández-Jiménez MC; Canales MA; Ojeda E; de Bustos JG; Aguado MJ; Hernández-Navarro F
    Haematologica; 1999 Nov; 84(11):1007-11. PubMed ID: 10553161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiation therapy in early stage Hodgkin's disease: long-term results and adverse effects.
    Zijlstra JM; Dressel AJ; Mens JW; Tinteren Hv; Slotman BJ; Jonkhoff AR; Huijgens PC
    Hematol J; 2002; 3(4):179-84. PubMed ID: 12189563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical presentation and outcome in lymphocyte-predominant Hodgkin's disease.
    Bodis S; Kraus MD; Pinkus G; Silver B; Kadin ME; Canellos GP; Shulman LN; Tarbell NJ; Mauch PM
    J Clin Oncol; 1997 Sep; 15(9):3060-6. PubMed ID: 9294468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [High-dose chemotherapy and autologous stem cell transplantation for refractory and relapsing Hodgkin's disease as first-line therapy-- studies at Sheba Medical Center--Tel Hashomer].
    Avigdor A; Hardan I; Shpilberg O; Raanani P; Grotto I; Ben-Bassat I
    Harefuah; 2000 Sep; 139(5-6):174-9, 248, 247. PubMed ID: 11062945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relapsed non-Hodgkin's lymphoma: detection and treatment.
    Shioyama Y; Nakamura K; Kunitake N; Kimura M; Terashima H; Masuda K
    Radiat Med; 2000; 18(6):369-75. PubMed ID: 11153690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Relapse in Hodgkin's disease. Incidence of relapse in a group of 374 patients from 1 June 1968 to 31 March 1995].
    Dienstbier Z; Hermanská Z; Zámecník J; Melínová L; Vacková B; Skala E; Srbová D
    Vnitr Lek; 1995 Dec; 41(12):816-21. PubMed ID: 8600652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Very late relapse of Hodgkin's disease after 24 years of complete remission.
    Dimopoulos MA; Kostis E; Anagnostopoulos A; Dalezios M; Papadimitris C; Papadimitriou C
    Leuk Lymphoma; 1997 Dec; 28(1-2):215-7. PubMed ID: 9498723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment for relapse in stage I/II Hodgkin's lymphoma after initial single-modality treatment.
    Rueda A; Olmos D; Viciana R; Alba E
    Clin Lymphoma Myeloma; 2006 Mar; 6(5):389-92. PubMed ID: 16640815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modality treatment in adult stage I-II Hodgkin's disease with large mediastinal masses: study of 30 cases and review of the literature.
    Grigoraki V; Lilienthal F; Touboul E; Gabarre J; Binet JL; Merle-Béral H
    Nouv Rev Fr Hematol (1978); 1993 Aug; 35(4):437-45. PubMed ID: 8414965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.